Publication | Closed Access

Synthesis, anticancer activity and molecular docking of new pyrazolo[1,5-a]pyrimidine derivatives as EGFR/HER2 dual kinase inhibitors

Medicinal ChemistryMolecular ModelingMedicinePharmacologyRational Drug DesignAnti-cancer AgentDrug DevelopmentMolecular DockingRadiation OncologyAnticancer ActivityDrug Discovery